Revolution Medicines, Inc. (RVMD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

190.13M
Year ended 2025-12-31
+33.1%
3-year compound annual growth
+28.2%
5-year compound annual growth
2020-12-31: 54.87M2021-12-31: 72.81M2022-12-31: 80.63M2023-12-31: 113.15M2024-12-31: 167.74M2025-12-31: 190.13M190.13M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31190.13M+13.3%2026-02-25, From 2025-01-01
2024-12-31167.74M+48.2%2026-02-25, From 2024-01-01
2023-12-31113.15M+40.3%2026-02-25, From 2023-01-01
2022-12-3180.63M+10.7%2025-02-26, From 2022-01-01
2021-12-3172.81M+32.7%2024-02-26, From 2021-01-01
2020-12-3154.87Mn/a2023-02-27, From 2020-01-01